logo
Questions? +1 (202) 335-3939 Login
Set Up FREE Account Submit Release
Trusted News Since 1995
A service for pharmaceutical industry professionals · Sunday, July 19, 2026 · 927,817,232 Articles · 3+ Million Readers
Home  •••  Newswires by Industry  •  Countries  •  U.S. States  •  World Media Directory
Pharmaceutical Industry News  •••  Topics  •  Countries  •  U.S. States

Formoterol News Monitoring

  • Published on Jul 16, 2026

    FDA Drug Approvals Q2 2026

    Otolaryngology  Otarmeni (lunsotogene parvec)  Lunsotogene parvec is an adeno-associated virus vector-based gene therapy indicated for the treatment of pediatric and adult patients with severe-to-profound and profound sensorineural hearing loss (any …

    Source: Medscape - Neutral
  • Published on Jul 16, 2026

    SMART Program Underutilized for Kids in Primary Asthma Care

    Single maintenance and relief therapy (SMART) is underutilized in asthmatic children treated in primary care, a survey-based clinician study in Pediatrics found. SMART uses a single inhaler combining an inhaled corticosteroid and formoterol, a rapid-acting …

    Source: Medscape - Neutral
  • Published on Jun 29, 2026

    China’s Bulk Drug Procurement Program Hits Quality Snags as Regulators Oust Suppliers

    1. Chinese regulators have disqualified more than 10 drug and medical-device companies from national bulk-procurement programs in 2025 after finding serious production or quality-management defects, highlighting safety concerns in a system designed to cut …

    Source: Caixin - Indeterminate
  • Published on Jun 29, 2026

    Comparative Effectiveness and Safety of Fluticasone-Umeclidinium-Vilanterol and Beclomethasone-Glycopyrronium-Formoterol ...

    Dear Editor We read with interest the manuscript by Cherian et al1 that reports on a comparison of real-world effectiveness and safety of two single-inhaler triple therapies (SITT) in patients with COPD in the UK. This large observational study builds upon …

    Source: Dove Medical Press - Neutral
  • Published on Jul 6, 2026

    First Half 2026 Recap - Pulmonology

    H1 2026 was a defining period for pulmonology, bookended by a landmark COPD biologic program, a first-in-class antifibrotic context from late 2025 entering routine practice, and the most consequential IPF trial readout in years. The 2026 American Thoracic …

    Source: Consultant Live - Pending
  • Published on Jun 26, 2026

    Real-Life Effectiveness of Aclidinium/Formoterol on COPD Control: The REDACT Observational Study

    Introduction COPD is one of the leading causes of morbidity and mortality worldwide,1 and will continue affecting millions of people in the following decades.2 The prevalence of COPD in Greece is 8.4% in adults over 35 years, higher in men (11.6%) than …

    Source: Dove Medical Press - Neutral
  • Published on Jul 3, 2026

    8 Pulmonology Headlines you Missed in Q2 2026

    Q2 2026 was anchored by the American Thoracic Society (ATS) 2026 International Conference in May and capped by expert coverage from the Association of Pulmonary Advanced Practice Providers (APAPP) National Conference in June. The quarter's defining …

    Source: Consultant Live - Pending
  • Published on Jun 27, 2026

    Withdrawn application: BiResp Spiromax, 27/04/2026

    The two active substances in BiResp Spiromax are well known and are present in several medicines used to treat asthma and COPD, either alone or in combination with other medicines. Budesonide belongs to a group of anti-inflammatory medicines known as …

    Source: European Medicines Agency - Pending
  • Published on Jun 22, 2026

    Profiles and Disease Burden of Patients with COPD Initiating Triple Therapy in China

    Introduction Chronic obstructive pulmonary disease (COPD) is a common respiratory disease characterised by persistent, often progressive, airflow limitation.1 It is one of the top three causes of death in China and accounted for 89.3 deaths per 100 000 …

    Source: Dove Medical Press - Neutral
  • «
  • 1
  • »

01 days 15:52:57

Featured Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.
Load more pharmaceuticals news or search news using your own keywords. There are 927,817,232 articles in our news database.

Online News Monitoring Made Simple

Established in 1995, EIN Newsdesk helps millions of users track breaking news across thousands of trusted websites. Users may set up custom email newsletters and RSS feeds or search among thousands of preset news sections. As a member, you may also submit your own news using the EIN Presswire distribution service. Membership is free and we do not sell or lease any information about you. Press release distribution, dedicated APIs, and custom services generate the revenue that allow us to offer you free basic access.

News by Country & by Industry

Worldwide News Coverage

Track news across more than 5,000 sources by country or industry or search our real-time news index.

Pharmaceutical Industry News by Country >
Pharmaceutical Industry News by U.S. State >
Pharmaceutical Industry News Topics >
Online News Publications >
World News Report >

News Alerts & News Feeds

Custom News Monitoring

News page results can be outputted as RSS or received daily by email. You may also use our NewsPlugin for WordPress.

Create Email Newsletter >
Create RSS Feed >
NewsPlugin for WordPress >

Submit News

PR Distribution Service

Our EIN Presswire's distribution footprint reaches millions. You can upload news which is re-published through EIN Newsdesk, fed into Twitter and Facebook, and onto partner sites, Google News, Bing News, etc.

EIN Presswire >
Events >

World Media Directory

News Media Guide

This is a listing of the world’s TV stations, radio stations, newspapers, and blogs. Last update: 07/12/2026

World Media Directory >

Healthcare & Pharmaceuticals Industry Press Releases

Got News to Share? · Submit · See All
Got news to share? Submit it now.

Healthcare & Pharmaceuticals Events

See All

No event was found.

Become a Member - Join Today!
Join thousands of professionals. Stay current. Stay competitive.
  • Track news from thousands of sources
  • Submit news sources for inclusion in our news tracking algorithm
  • Build your own customized email newsletters
  • Use of our RSS Feeds
  • Includes a complimentary EIN Presswire account plus 1-free release
  • Uncluttered & advertising free news pages

Pharmaceutical Industry Today by EIN Newsdesk & EIN Presswire (a press release distribution service)

Follow EIN Presswire on Facebook, LinkedIn and Substack

Newsmatics Inc., 1025 Connecticut Avenue NW, Suite 1000, Washington, DC 20036 · Contact · About

© 1995-2026 Newsmatics Inc. · All Rights Reserved · General Terms & Conditions · Privacy Policy · Cookie Settings

By continuing to use this site, you agree to our Terms & Conditions, last updated on September 30, 2025.